VanEck Associates’s Nuveen Short-Term REIT ETF NURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-110,995
Closed -$3.43M 1408
2023
Q4
$3.43M Buy
110,995
+10,433
+10% +$291K 0.01% 645
2023
Q3
$2.73M Sell
100,562
-8,364
-8% -$246K 0.01% 665
2023
Q2
$3.31M Buy
108,926
+71,437
+191% +$2.14M 0.01% 610
2023
Q1
$1.11M Sell
37,489
-5,626
-13% -$170K ﹤0.01% 807
2022
Q4
$1.23M Sell
43,115
-1,799
-4% -$53.1K ﹤0.01% 765
2022
Q3
$1.33M Sell
44,914
-3,900
-8% -$131K ﹤0.01% 729
2022
Q2
$1.57M Buy
48,814
+26,520
+119% +$948K ﹤0.01% 708
2022
Q1
$872K Buy
22,294
+12,422
+126% +$474K ﹤0.01% 856
2021
Q4
$402K Buy
9,872
+4,020
+69% +$153K ﹤0.01% 989
2021
Q3
$207K Buy
5,852
+1,784
+44% +$64.2K ﹤0.01% 1024
2021
Q2
$138K Buy
+4,068
New +$133K ﹤0.01% 1052

Other funds holding NURE

VanEck Associates's NURE Position: Q1 2024 in Review

VanEck Associates sold out of Nuveen Short-Term REIT ETF (NURE) in Q1 2024, closing a stake of 110,995 shares — an estimated $3.43M sold.

VanEck Associates first reported a position in NURE in Q2 2021 and held it in 11 quarters. The position peaked at $3.43M in Q4 2023. 31 funds tracked by Wall St. Rank hold NURE as of Q1 2024.

  • VanEck Associates reported no remaining Nuveen Short-Term REIT ETF position as of Q1 2024 after selling out during the quarter.
  • VanEck Associates sold 110,995 Nuveen Short-Term REIT ETF shares in Q1 2024, an estimated $3.43M.
  • VanEck Associates first reported a position in Nuveen Short-Term REIT ETF in Q2 2021 and held it in 11 quarters.
  • VanEck Associates's Nuveen Short-Term REIT ETF position peaked at $3.43M in Q4 2023.
  • 31 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q1 2024.

Based on VanEck Associates's 13F filing for Q1 2024, filed 30 Apr 2024.